THE PENTRAXINS, C-REACTIVE PROTEIN AND SERUM AMYLOID-P COMPONENT, ARE CLEARED AND CATABOLIZED BY HEPATOCYTES IN-VIVO

被引:67
作者
HUTCHINSON, WL [1 ]
NOBLE, GE [1 ]
HAWKINS, PN [1 ]
PEPYS, MB [1 ]
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,MED IMMUNOL UNIT,LONDON W12 0NN,ENGLAND
关键词
ACUTE PHASE PROTEINS; AMYLOID P COMPONENT; CLEARANCE; C-REACTIVE PROTEIN; HEPATOCYTE;
D O I
10.1172/JCI117474
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The cellular sites of clearance and degradation of the pentraxin plasma proteins, C-reactive protein, the classical acute phase reactant, and serum amyloid P component (SAP), a universal constituent of amyloid deposits, were sought using the ligand I-125-tyramine cellobiose (TC) which is substantially retained within the cells in which catabolism takes place. Pentraxins labeled with I-125-TC showed the same in vitro and in vivo ligand binding and the same in vivo plasma t(1/2) as the directly iodinated proteins and the native unlabeled pentraxins, indicating that their mode of clearance was likely to be physiological. After intravenous injection into mice and rabbits of human C-reactive protein, human SAP, and mouse SAP, each labeled with I-125-TC, most of the radioactivity remaining in the body at 24 h was located in hepatocytes. None was detected in other liver cells, and only traces were present in other viscera; the rest was in the carcass, representing intact pentraxins in the blood and extravascular compartment, and escaped label which had not yet been excreted. Hepatocytes are thus the single major site of pentraxin clearance and catabolism in vivo. This is consistent with the observation that SAP that has localized to amyloid deposits persists there and is not degraded.
引用
收藏
页码:1390 / 1396
页数:7
相关论文
共 39 条
  • [1] BALTZ ML, 1980, CLIN EXP IMMUNOL, V39, P355
  • [2] BALTZ ML, 1986, CLIN EXP IMMUNOL, V66, P691
  • [3] BALTZ ML, 1985, CLIN EXP IMMUNOL, V59, P235
  • [4] AMYLOIDOSIS AND FEMALE PROTEIN IN THE SYRIAN-HAMSTER - CONCURRENT REGULATION BY SEX-HORMONES
    COE, JE
    ROSS, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (04) : 1257 - 1267
  • [5] ISOLATION OF HUMAN C-REACTIVE PROTEIN AND SERUM AMYLOID P COMPONENT
    DEBEER, FC
    PEPYS, MB
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 50 (01) : 17 - 31
  • [6] STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID-P COMPONENT
    EMSLEY, J
    WHITE, HE
    OHARA, BP
    OLIVA, G
    SRINIVASAN, N
    TICKLE, IJ
    BLUNDELL, TL
    PEPYS, MB
    WOOD, SP
    [J]. NATURE, 1994, 367 (6461) : 338 - 345
  • [7] FLITNEY E, 1990, THEORY PRACTICE HIST, P645
  • [8] GLASS CK, 1983, J BIOL CHEM, V258, P7161
  • [9] ROLE OF LIPOPROTEIN-LIPASE IN THE REGULATION OF HIGH-DENSITY-LIPOPROTEIN APOLIPOPROTEIN METABOLISM - STUDIES IN NORMAL AND LIPOPROTEIN LIPASE-INHIBITED MONKEYS
    GOLDBERG, IJ
    BLANER, WS
    VANNI, TM
    MOUKIDES, M
    RAMAKRISHNAN, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) : 463 - 473
  • [10] GUSTAFSON S, 1990, J LIPID RES, V31, P183